2 / 9
Page 20
Notes:
allied
academies
Joint Event
February 21-22, 2019 | Paris, France
Microbiology & Applied
Microbiology
2
nd
International Conference on
World Congress on
Wound Care, Tissue Repair
and Regenerative Medicine
&
Journal of Trauma and Critical Care | Volume 3
The use of amniotic membrane in healing excisional debridement of sea urchin stings
Clifton Peele, Sarah Foyle
and
Barbara Saar
University Hospitals Richmond Medical Center, USA
S
ea urchin stings have plagued many people and most
commonly affect the feet. Many physicians in literature have
described treatments for these traumas. The various treatment
options for sea urchin stings range from soaking the feet in
vinegar to help detach the barbs, to antibiotic therapy with
narcotics for pain control. However, in an extensive review of
literature, Dehydrated Human Amnion/ChorionMembrane has
not yet beenused to treat seaurchinstings. Allograftshavebeen
used to treat every type of traumatic condition and chronic foot
ulcers that affect every type of population. Now Allografts such
as Dehydrated Human Amnion/ChorionMembrane have found
a new usefulness in the treatment of Sea Urchin stings. The
Dehydrated Human Amnion/Chorion Membrane can reduce
the scar tissue formation, decrease skin contracture and return
to normal epithelialize skin.
Speaker Biography
Clifton Peele is a native of Eastern North Carolina, where he earned his Bachelor of
Science Degree from East Carolina University. After which he earned his doctorate
in podiatric medicine from the renowned Des Moines University in Des Moines,
Iowa. Advancing his training as a preceptor at One Foot Two Foot Clinic in Suffolk,
VA. He completed his medical and surgical training at the prestigious Howard
University Hospital in Washington, D.C. He was fortunate to be accepted to a two-
year fellowship in wound care and diabetic limb salvage at University Hospital in
Cleveland, OH. Currently, he is a podiatrist at Total Foot Care Clinic in Hattiesburg, MS.
e:
clp1906@yahoo.comClifton Peele et al.
, J Trauma Crit Care, Volume 3
DOI: 10.4066/2591-7358-C1-002